When Expanded Access Also Means Off-Label Use, US FDA May Need New Policy

 
• By Derrick Gingery
  
FDA entrance sign 2016
FDA has encountered situations where an expanded access IND is necessary to allow an off-label use of an approved drug.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards